Viewing Study NCT01318135


Ignite Creation Date: 2025-12-24 @ 10:03 PM
Ignite Modification Date: 2026-05-21 @ 12:28 PM
Study NCT ID: NCT01318135
Status: COMPLETED
Last Update Posted: 2012-08-16
First Post: 2011-03-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan
Sponsor: Takeda
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes Mellitus - Type 2 View
None Diabetes Mellitus View
None Drug Therapy View